XML 37 R12.htm IDEA: XBRL DOCUMENT v3.25.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
The changes in the carrying amount of goodwill for the year ended December 31, 2024 are as follows by reporting segment:
Aptar
Pharma		Aptar
Beauty		Aptar
Closures		Total
Balance as of December 31, 2022$498,742 $319,011 $127,879 $945,632 
Reclassification due to segment change— (39,472)39,472 — 
Acquisition— 4,603 114 4,717 
Foreign currency exchange effects9,705 2,955 409 13,069 
Balance as of December 31, 2023$508,447 $287,097 $167,874 $963,418 
Foreign currency exchange effects(20,213)(5,811)(1,138)(27,162)
Balance as of December 31, 2024$488,234 $281,286 $166,736 $936,256 
Effective January 1, 2023, we realigned two of our segment, allowing us to better serve our customers and position us for long-term profitable growth; see Note 18 - Segment Information for additional information. As a result of this segment realignment, we reassigned a total of $39.5 million of goodwill from the Beauty reporting unit to the Closures reporting unit using the relative fair value approach.
We have completed the annual impairment analysis of our reporting units as of October 1, 2024. As we performed our annual goodwill impairment assessment, due to events or circumstances that were unfavorable for injectables and the passage of time from our prior Step 1 analysis over the other pharma reporting unit, management determined it appropriate to calculate the fair value of both reporting units and compare with their associated carrying amounts as of October 1, 2024.
We estimated the fair values of the affected businesses based upon the present value of their estimated future cash flows. Our determination of fair value involved judgment and the use of significant estimates and assumptions, including assumptions regarding the projected revenue growth rates, projected EBITDA margins, as well as the discount rate to calculate estimated future cash flows. We believe that our assumptions used in discounting future cash flows are appropriate.
Based on our review of macroeconomic, industry, and market events and circumstances as well as the overall financial performance of the reporting units, we determined that it was more likely than not that the fair value of these reporting units was greater than their carrying amounts. No impairment was recognized during the years ended December 31, 2024, 2023 or 2022.
The table below shows a summary of intangible assets for the years ended December 31, 2024 and 2023.
20242023
Weighted Average
Amortization Period
(Years)		Gross
Carrying
Amount		Accumulated
Amortization		Net
Value		Gross
Carrying
Amount		Accumulated
Amortization		Net
Value
Amortized intangible assets:
Patents12.6$18,333 $(2,343)$15,990 $7,362 $(1,754)$5,608 
Acquired technology11.2137,444 (80,171)57,273 142,837 (70,520)72,317 
Customer relationships13.6303,502 (145,772)157,730 308,889 (124,648)184,241 
Trademarks and trade names8.042,882 (36,450)6,432 43,932 (33,368)10,564 
License agreements and other19.526,318 (8,974)17,344 17,213 (6,732)10,481 
Total intangible assets13.3$528,479 $(273,710)$254,769 $520,233 $(237,022)$283,211 
During the year ended December 31, 2024, we purchased $17.7 million of intangibles primarily associated with the purchase of patents of $12.4 million and other intangible assets. Aggregate amortization expense for the intangible assets above for the years ended December 31, 2024, 2023 and 2022 was $44,117, $44,720 and $43,574, respectively.
Future estimated amortization expense for the years ending December 31 is as follows:
2025$42,075 
202640,923 
202733,358 
202829,374 
202927,283 
2030 and thereafter81,756 
Future amortization expense may fluctuate depending on changes in foreign currency rates. The estimates for amortization expense noted above are based upon foreign exchange rates as of December 31, 2024.